(Q38222880)

31 August 2017

title

The role of post-translational modifications in acute and chronic cardiovascular disease (English)

1 reference

31 August 2017

author

Lauren Elizabeth Smith

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961403%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Melanie Y White

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961403%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

1 August 2014

1 reference

Proteomics - Clinical Applications

31 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961403%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961403%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

7-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961403%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

506-521

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961403%20AND%20SRC:MED&resulttype=core&format=json

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

KATP channels and cardiovascular disease: suddenly a syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Cardiac signaling genes exhibit unexpected sequence diversity in sporadic cardiomyopathy, revealing HSPB7 polymorphisms associated with disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

A common variant on chromosome 9p21 affects the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

A common allele on chromosome 9 associated with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Association of a human G-protein beta3 subunit variant with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Genetic evaluation of dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Genetic cardiomyopathies causing heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Congenital Heart Defects in Europe: Prevalence and Perinatal Mortality, 2000 to 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Overview of high throughput sequencing technologies to elucidate molecular pathways in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Mapping and quantifying mammalian transcriptomes by RNA-Seq

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

The transcriptional landscape of the yeast genome defined by RNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Highly integrated single-base resolution maps of the epigenome in Arabidopsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Defining the transcriptome and proteome in three functionally different human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Multiple Reaction Monitoring to Identify Site-Specific Troponin I Phosphorylated Residues in the Failing Human Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Release of tissue-specific proteins into coronary perfusate as a model for biomarker discovery in myocardial ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Modifications of myosin-regulatory light chain correlate with function of stunned myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Functional dissection of myosin binding protein C phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Cardiac myosin binding protein C: its role in physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Phosphorylation and function of cardiac myosin binding protein-C in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

A critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Phosphorylation states of phospholamban

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Phospholamban phosphorylation sites enhance the recovery of intracellular Ca2+ after perfusion arrest in isolated, perfused mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Protein kinase activation and myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Effect of pressure overload on cardioprotection via PI3K-Akt: comparison of postconditioning, insulin, and pressure unloading

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Interactions between the regulatory subunit of type I protein kinase A and p90 ribosomal S6 kinase1 regulate cardiomyocyte apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

The signalling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Ca2+/Calmodulin-dependent protein kinase II δ mediates myocardial ischemia/reperfusion injury through nuclear factor-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

O-GlcNAc modification in diabetes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Large-scale capture of peptides containing reversibly oxidized cysteines by thiol-disulfide exchange applied to the myocardial redox proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Physiological roles of mitochondrial reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Oxidation of myofibrillar proteins in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Oxidation of HRas cysteine thiols by metabolic stress prevents palmitoylation in vivo and contributes to endothelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation - a novel antiapoptotic mechanism that suppresses apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Site-mapping of in vitro S-nitrosation in cardiac mitochondria: implications for cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Does reversible cysteine oxidation link the Western diet to cardiac dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Advanced glycation endproducts--role in pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Unlocking the biology of RAGE in diabetic microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Advanced glycation end-products: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Oxidative stress and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Advanced glycation end products: role in pathology of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

The mechanism of collagen cross-linking in diabetes: a puzzle nearing resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Advanced glycation end-products and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Novel regulation of cardiac Na pump via phospholemman.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Regulation of the cardiac sodium pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Heart mitochondria: gates of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Cardioprotection: a radical view Free radicals in pre and postconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

GSK-3beta, a therapeutic target for cardiomyocyte protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Postconditioning the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Postconditioning the human heart in percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Why do we still not have cardioprotective drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Hyperglycemia and cardiovascular disease in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Coronary artery bypass grafting in type II diabetic patients: a comparison between insulin-dependent and non-insulin-dependent patients at short- and mid-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Preconditioning the diabetic human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Oxidative stress and myocardial injury in the diabetic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

The genetics of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400052

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

15 July 2023

Identifiers

DOI

10.1002/PRCA.201400052

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961403%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference